A patient who will begin using nitroglycerin for angina asks the primary care NP how the medication works to relieve pain. The NP should tell the patient that nitroglycerin acts to:
a. dissolve atheromatous lesions.
b. relax vascular smooth muscle.
c. prevent catecholamine release.
d. reduce C-reactive protein levels.
B
Nitrates relax vascular smooth muscle via stimulation of intracellular cyclic guanosine monophosphate production with the major effect being to reduce myocardial oxygen demand. Nitrates do not dissolve atheromatous lesions, prevent catecholamine release, or reduce C-reactive protein levels.
You might also like to view...
A client has a nursing diagnosis of Risk for Impaired Skin Integrity related to prescribed bed rest and decreased sensation and mobility of the lower extremities. What type of nursing diagnosis is this classified as?
A) Actual diagnosis B) Health promotion diagnosis C) Risk diagnosis D) Syndrome diagnosis
The nurse is providing a medication to a client that will stimulate the sympathetic nervous system. This medication will cause which effects to the client?
Standard Text: Select all that apply. 1. Increased heart rate 2. Increased blood pressure 3. Increased respirations 4. Dilated pupils 5. Decreased body temperature
Statistical heterogeneity is an issue in meta-analysis and affects decisions about using a single true effect size. What is the name for this single true effect size?
A) Inverse variance B) Fixed effects model C) Random effects model D) Forest plot
Which patients are eligible to receive erythropoiesis stimulating agents? (Select all that apply.)
a. All patients with nonmyeloid malignancies who require transfusions b. All patients with nonmyeloid malignancies whose chemotherapy is palliative c. All patients whose goal of therapy is curative d. All patients with nonmyeloid malignancies and chemotherapy-induced anemia e. All patients with leukemias or myeloid malignancies